Replies to post #234202 on Kraig Biocraft Laboratories Inc (KBLB)

[GTman1]

Excellent find.

Those descriptions have a much clearer meaning after reading through their new tech.

This is also a good time to remind people that these patent apps aren't new. They were just published today for the public. But this tech was filed to the patent office 18 months ago, which means it's been in development for much longer. This tech is closer to realization than some think.

Below is the full text from the PR:

KRAIG BIOCRAFT LABORATORIES EXPANDS INTELLECTUAL PROPERTY PORTFOLIO
ANN ARBOR, Mich., – August 5, 2021 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that the Company has further expanded its leading position in the development of recombinant spider silk with the filing of two new patent applications. These new innovative patents build upon underlying knock-in/knock-out gene-editing technologies that the Company first made public in 2020.

The technologies covered with these patents expand on the Company’s nearly pure spider silk genetic engineering systems allowing for larger, more complex, and more diverse protein production systems.

Leveraging in situ auto assembly of large and complex proteins, the first, of these two patents, allows for the creation of silks that incorporate multiple sets of mechanical and chemical properties that cannot be created by conventional gene editing means. Kraig Labs developed this new system to address the limits on size and complexity of protein synthesis available from the world’s leading recombinant gene manufacturers. The Company expects that this new method will produce silks with complexities and scope that have never been seen before, in nature or in the laboratory.

The second patent propels the Company’s developments in gene editing beyond the traditional heavy chain fibroin component of silk. This new research and development avenue opens the doors for the co-production of complementary proteins. This evolution in research delivers on the Company’s vision for its transgenic silkworms as host platforms for tailored cosmetic and pharmacological proteins. This new system leverages the cost-effective and eco-responsible protein system that all of the Company’s technologies are built on.

The Company filed both of these patent applications under the World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT) process as well as filing utility patents in the United States of America. The broad nature of the PCT application will allow the Company to protect its technologies across the globe.

“Our research team continues to impress, bring new and innovative ideas to transcend what others may see as a technological limitation,” said COO Jon Rice. “The portfolio of IP that our team is building, together with the resulting silk technologies it has produced, leaves me very optimistic for the future of Kraig Labs, our spider silk technologies, and beyond.”